1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The relationship between familial-genetic risk and pharmacological treatment in a Swedish national sample of patients with major depression, bipolar disorder, and schizophrenia
(
- Contribution to journal › Article
- 2023
-
Mark
Selecting cases of major psychiatric and substance use disorders in Swedish national registries on the basis of clinical features to maximize the strength or specificity of the genetic risk
(
- Contribution to journal › Article
-
Mark
Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau
(
- Contribution to journal › Article
-
Mark
NG2-glia : rising stars in stress-related mental disorders?
(
- Contribution to journal › Letter
- 2022
-
Mark
Thalamic dopamine D2-receptor availability in schizophrenia : a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis
(
- Contribution to journal › Article
-
Mark
Dopamine and fear memory formation in the human amygdala
(
- Contribution to journal › Article
-
Mark
Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia
(
- Contribution to journal › Article
-
Mark
Brain integrity is altered by hepatic APOE ε4 in humanized-liver mice
(
- Contribution to journal › Article
- 2021
-
Mark
Prediction of clinical diagnosis of Alzheimer’s disease, vascular, mixed, and all-cause dementia by a polygenic risk score and APOE status in a community-based cohort prospectively followed over 17 years
(
- Contribution to journal › Article
-
Mark
Gene-educational attainment interactions in a multi-ancestry genome-wide meta-analysis identify novel blood pressure loci
(
- Contribution to journal › Article